Ua ʻae ʻo FDA i kahi pana COVID-19 Booster no ka poʻe Immunocompromised

Anter

• Nānā no

Me nā ʻike hou e pili ana i ka COVID-19 e hāpai nei i kēlā me kēia lā - me ka piʻi pū ʻana o nā hihia ma ka ʻāina holoʻokoʻa - maopopo ia inā he nīnau kāu e pili ana i kahi e pale pono ai, ʻoiai inā ua hoʻopiha piha ʻia ʻoe. A ʻoiai ke holo nui nei ka kamaʻilio ʻana o nā pana hoʻoikaika COVID-19 i kekahi mau pule i hala aku nei, ʻo ka loaʻa ʻana o kahi maʻi hou e lilo i mea maoli no kekahi manawa koke.

Ua ʻae ʻia ka Food and Drug Administration i ke kolu o nā koina o nā lāʻau ʻelua o Moderna a me Pfizer-BioNTech COVID-19 no ka poʻe immunocompromised, ua hoʻolaha ka hui i ka Pōʻalima. Ke hele mai nei ka neʻe ʻana i ka hoʻomau ʻana o ka ʻano ʻokoʻa Delta ma waena o ka ʻāina, e helu ana no 80 pakeneka o nā hihia COVID-19 ma US, e like me ka ʻikepili hou mai nā Centers for Disease Control and Prevention. (Pili: Pehea ka maikaʻi o ka Vaccine COVID-19?)

ʻOiai ʻo ka coronavirus he mea hoʻoweliweli maopopo i nā mea āpau, ka loaʻa ʻana o kahi ʻōnaehana nāwaliwali - ʻo ia ka hihia ma kahi o ʻekolu pākēneka o ka lehulehu o ka U.S. - "hiki iā ʻoe ke maʻi ʻino loa mai COVID-19," e like me ka CDC. Ua ʻike ka hui i ka immunocompromised ma ke ʻano he loaʻa i nā transplants organ, nā mea e mālama ʻia ana i ka maʻi ʻaʻai, ka poʻe me ka maʻi HIV / AIDS, a me nā maʻi me nā maʻi hoʻoilina e pili ana i ka ʻōnaehana paleʻea, a me nā mea ʻē aʻe. Ua ʻōlelo ka FDA ma kahi nūpepa i ka Pōʻalima, ʻo ka poʻe e ʻae ʻia no ke kolu o ka pana ʻana, ʻo ia ka poʻe i loaʻa i nā mea hoʻololi o ke kino paʻa (e like me nā puʻupaʻa, nā ate, a me nā puʻuwai), a i ʻole nā ​​​​mea like me ka immunocompromised.

"ʻO ka hana o kēia lā e hiki ai i nā kauka ke hoʻonui i ka pale ʻana i kekahi poʻe immunocompromised e pono ai ka pale hou mai COVID-19," wahi a Janet Woodcock, M.D., ke Komisina FDA, ma kahi ʻōlelo i ka Pōʻalima.

Ke hoʻomau nei ka noiʻi ʻana i ke kolu o ka maʻi o kahi kano COVID-19 no ka immunocompromised no kekahi manawa. I kēia mau lā, ua ʻimi nā kānaka noiʻi ma John Hopkins Medine aia he mau hōʻike e hōʻike ai pehea e hoʻonui ai i ʻekolu mau lāʻau o ka lāʻau lapaʻau i nā pae pale pale kūʻē e kūʻē iā SARS-SoV-2 (aka, ʻo ka maʻi hoʻomaʻamaʻa ka mea e loaʻa ai ka maʻi) i nā mea loaʻa transplant solid, e kūʻē ana i ka lāʻau ʻelua. ʻōpū. Ma muli o ke koi pinepine ʻia ʻana o ka poʻe me nā transplants i nā lāʻau e hoʻopau i nā lāʻau "e kāohi i kā lākou ʻōnaehana pale a pale i ka hōʻole ʻia" o kahi transplant, e like me ka noiʻi, aia ka hopohopo no ka hiki i ke kanaka ke hana i nā mea pale i nā mea haole. I ka pōkole, ua hōʻike ʻo 24 o nā noi 30 i ʻaʻohe mea ʻāpilikia i ʻike ʻia e kūʻē iā COVID-19 ʻoiai i hoʻopiha ʻia i ka lāʻau āpau. ʻOiai, i ka loaʻa ʻana o ke kolu o ka lāʻau, ua ʻike ka hapakolu o nā mea maʻi i ka hoʻonui ʻia o nā pae antibody. (E heluhelu hou aku: Eia nā mea a pau e pono ai ʻoe e ʻike e pili ana i ka Coronavirus a me nā Deficiencies Immune)

Hoʻonohonoho ʻia nā kikowaena no ke kaohi aʻoaʻo a me ka pale ʻana no ka maʻi no ka hoʻomaʻamaʻa ʻana i ka maʻi ma ka Pōʻalima e kūkākūkā hou aku ai i nā ʻōlelo aʻoaʻo e pili ana i ka poʻe immunocompromised. I kēia manawa, ua ʻae ʻia nā ʻāina ʻē e nā booster dosis no nā kānaka immunocompromised, e like me Palani, Kelemania, a me Hungary, e like me ʻO ka New York Times.

I kēia manawa, ʻaʻole i ʻae ʻia nā mea hoʻouluulu no ka poʻe me nā ʻōnaehana pale olakino, no laila he mea koʻikoʻi ka loaʻa ʻana o nā poʻe āpau i kūpono i ka maʻi COVID-19. Me nā pale masks, ʻo ia ka pili ʻoi loa e pale aku i ka poʻe me nā ʻōnaehana pale nawaliwali a i ʻole nā ​​mea i loaʻa ʻole ka pana.

Pololei ka ʻike ma kēia moʻolelo e like me ka manawa paʻi. Ke hoʻomau nei nā mea hou e pili ana i ka coronavirus COVID-19, ua loli paha kekahi mau ʻike a me nā manaʻo o kēia moʻolelo mai ka hoʻolaha mua ʻana. Paipai mākou iā ʻoe e nānā pinepine me nā kumuwaiwai e like me ka CDC, ka WHO, a me kāu keʻena olakino kūloko kūloko no ka ʻikepili a me nā ʻōlelo aʻoaʻo hou loa.

Nānā no